Softox Solutions A.S. Navne-Aksjer NK 0,02

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

53.49%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

0.00 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.004 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 09:56:22 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0040.0029
PREV. DAY'S PRICE0.0039 (07/22)
CHANGE DAY BEFORE
+0.00
2.56 %
52 WEEK HIGH / LOW0.0144 (04/14)0.0003 (07/06)

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.080.000.00--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
14.690.299.15--
PRICE - SALES RATIO
-----
PRICE - CASH FLOW RATIO
45.930.84---
Further Key Figures

Master Data

WKN
A2JNDN
ISIN
NO0010811961
SYMBOL
6FV
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
SOFTOX SOLUTIONS NK 0,02
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
0.00 %
-60.00 %
-57.89 %
-20.00 %
-53.49 %
-98.67 %
-99.79 %
-42.86 %
HIGH0.000.010.010.010.010.363.880.01
LOW0.000.000.000.000.000.000.000.00

Dividende

pro Aktie
SOFTOX SOLUTIONS NK 0,02 does not deliver dividend information

Company profile

SoftOx Solutions AS engages in research and product development. It develops antiseptic agents to prevent and treat problematic skin infections with high unmet needs and aims to help and overcome the global challenge of antibiotic resistance with its novel solutions. The company was founded by Kristian Almas and Geir Hermod Almas on June 21, 2012 and is headquartered in Oslo, Norway.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.